Abstract | BACKGROUND: METHODS/DESIGN: This is a multicenter, crossover, double-blind study comparing active versus sham tDCS (2 mA, 30 min), applied over the dorsolateral prefrontal cortex for five consecutive days in 50 BPD patients. Participants will be assessed for impulsivity, depressive symptoms, and suicide risk. The main efficacy criteria on reduction of impulsivity will be the amplitude variation of one specific evoked potential detected by electroencephalography (EEG) during the balloon analogue risk task. Baseline measures will be compared to scores obtained immediately after sessions, then 12 and 30 days later. DISCUSSION: This study investigates the safety and effects of tDCS, which may have a significant impact on impulsivity in patients with BPD and may be useful to reduce risky behaviors. TRIAL REGISTRATION: ClinicalTrials.gov, NCT03498937 . Registered on 17 April 2018.
|
Authors | Juliana Teti Mayer, Magali Nicolier, Damien Gabriel, Caroline Masse, Julie Giustiniani, Charline Compagne, Pierre Vandel, Lionel Pazart, Emmanuel Haffen, Djamila Bennabi |
Journal | Trials
(Trials)
Vol. 20
Issue 1
Pg. 347
(Jun 10 2019)
ISSN: 1745-6215 [Electronic] England |
PMID | 31182143
(Publication Type: Clinical Trial Protocol, Journal Article)
|
Topics |
- Borderline Personality Disorder
(psychology, therapy)
- Cross-Over Studies
- Double-Blind Method
- Humans
- Impulsive Behavior
- Multicenter Studies as Topic
- Outcome Assessment, Health Care
- Randomized Controlled Trials as Topic
- Transcranial Direct Current Stimulation
(methods)
|